Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019

IMPORTANCE: Children of all ages appear susceptible to severe acute respiratory syndrome coronavirus 2 infection. To support pediatric clinical studies for investigational treatments of coronavirus disease 2019 (COVID-19), pediatric-specific dosing is required. OBJECTIVE: To define pediatric-specifi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:JAMA Pediatr
Main Authors: Maharaj, Anil R., Wu, Huali, Hornik, Christoph P., Balevic, Stephen J., Hornik, Chi D., Smith, P. Brian, Gonzalez, Daniel, Zimmerman, Kanecia O., Benjamin, Daniel K., Cohen-Wolkowiez, Michael
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2020
Teme:
Original Investigation
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7275264/
https://ncbi.nlm.nih.gov/pubmed/32501511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapediatrics.2020.2422
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki